DARA
BioSciences, Inc.
(NASDAQ: DARA), a specialty pharmaceutical
company focused on oncology and oncology supportive care products, announced
today that on February 12, 2013, NASDAQ notified the Company that it has...

DARA BioSciences, Inc. (NASDAQ: DARA) (the "Company" or "DARA"), a
specialty pharmaceutical company focused on oncology and oncology
supportive care products, announced today the Company will be presenting
at the...

DARA BioSciences, Inc. (Nasdaq: DARA) (the "Company" or "DARA"), a
specialty pharmaceutical company focused on oncology and oncology
supportive care products, announced today the Company will be presenting
at the...

DARA BioSciences, Inc. (Nasdaq:DARA) (the "Company" or "DARA") announced
that it entered into a definitive securities purchase agreement with
certain investors providing for the issuance of $2,800,000 of shares of
...

DARA
BioSciences, Inc. (NASDAQ: DARA), a specialty pharmaceutical company
focused on oncology and oncology supportive care products, announced
today it has submitted an Orphan Drug Application to the U.

DARA
BioSciences, Inc. (NASDAQ: DARA), a specialty pharmaceutical company
focused on oncology and oncology supportive care products, announced
today it will present at the New York Society of Security Analysts' 16th
...

DARA
BioSciences, Inc. (NASDAQ: DARA), a specialty pharmaceutical company
focused on oncology and oncology supportive care products, announced
today it will present at the Singular Research seventh annual “Best...

Breast Cancer Awareness Month raises visibility and research dollars to
address a disease that in the United States claims nearly 40,000 lives
annually and affects approximately 240,000 people who each year are
newly...

DARA BioSciences, Inc. (NASDAQ: DARA), a specialty pharmaceutical
company focused on oncology and oncology support products (the
“Company”), announced today that on October 1, 2012, NASDAQ notified the
...

DARA
BioSciences, Inc. (NASDAQ: DARA), a specialty pharmaceutical company
focused on oncology and oncology support products, announced today it
has a completed a series of agreements with a number of specialty
...

DARA
BioSciences, Inc. (
NASDAQ: DARA), a specialty pharmaceutical
company focused on the development and commercialization of oncology
treatment and supportive care products, announced today the appointment
...